79 related articles for article (PubMed ID: 12674632)
1. [Mapping of BRCT1 domain of BRCA1 with chromatin unfolding activity].
Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
Sheng Wu Gong Cheng Xue Bao; 2002 Nov; 18(6):656-61. PubMed ID: 12674632
[TBL] [Abstract][Full Text] [Related]
2. [Studies of mutations in BRCA1 transactivation domain by visualization of chromatin structure].
Ye QN; Hu YF; Zhong HJ; Li R; Huang CF
Yi Chuan Xue Bao; 2002; 29(11):941-8. PubMed ID: 12645254
[TBL] [Abstract][Full Text] [Related]
3. [Isolation and characterization of a BRCA1-interacting protein].
Yan JH; Ye QN; Zhu JH; Zhong HJ; Zheng HY; Huang CF
Yi Chuan Xue Bao; 2003 Dec; 30(12):1161-6. PubMed ID: 14986435
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
Williams RS; Green R; Glover JN
Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
[TBL] [Abstract][Full Text] [Related]
5. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
[TBL] [Abstract][Full Text] [Related]
6. TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.
Wright RH; Dornan ES; Donaldson MM; Morgan IM
Biochem J; 2006 Dec; 400(3):573-82. PubMed ID: 16984230
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
Drikos I; Nounesis G; Vorgias CE
Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.
Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND
Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400
[TBL] [Abstract][Full Text] [Related]
9. Effects of deletion and site-directed mutations on ligation steps of NAD+-dependent DNA ligase: a biochemical analysis of BRCA1 C-terminal domain.
Feng H; Parker JM; Lu J; Cao W
Biochemistry; 2004 Oct; 43(39):12648-59. PubMed ID: 15449954
[TBL] [Abstract][Full Text] [Related]
10. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.
Ye Q; Hu YF; Zhong H; Nye AC; Belmont AS; Li R
J Cell Biol; 2001 Dec; 155(6):911-21. PubMed ID: 11739404
[TBL] [Abstract][Full Text] [Related]
11. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
Gough CA; Gojobori T; Imanishi T
Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of a new BRCA1 variant: A role for BRCT domains in apoptosis.
Gu M; Li H; Shen C; Wu L; Liu W; Miao L; Zheng C
Cancer Lett; 2010 Sep; 295(2):205-13. PubMed ID: 20356671
[TBL] [Abstract][Full Text] [Related]
14. Cancer predisposing mutations in BRCT domains.
di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
[TBL] [Abstract][Full Text] [Related]
15. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
[TBL] [Abstract][Full Text] [Related]
16. Regulation of large-scale chromatin unfolding by Smad4.
Yan J; Fang Y; Ding L; Zhu J; Lu Q; Huang C; Yang X; Ye Q
Biochem Biophys Res Commun; 2004 Mar; 315(2):330-5. PubMed ID: 14766211
[TBL] [Abstract][Full Text] [Related]
17. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
[TBL] [Abstract][Full Text] [Related]
18. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
[TBL] [Abstract][Full Text] [Related]
19. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Williams RS; Lee MS; Hau DD; Glover JN
Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
